31 |
Immunoassays for glycosylation of alpha-1-acid glycoproteinAnderson, Ross C. January 1997 (has links)
No description available.
|
32 |
Polymorphonuclear leucocyte function in pregnancyCrocker, Ian Paul January 2000 (has links)
No description available.
|
33 |
Inflammatory diseases in mice lacking interleukin-1 receptor antagonistShepherd, Joanna January 2003 (has links)
No description available.
|
34 |
Regulation of osteoclast activity : differential adhesion of osteoclasts to the bone surfaceO'Brien, Elizabeth Ann January 2000 (has links)
No description available.
|
35 |
The nature, extent and functional impact of foot problems in established rheumatoid arthritisGosai, Hema 10 November 2009 (has links)
M.Sc.(Med.), Faculty of Health Sciences, University of the Witwatersrand, 2009 / Introduction
Foot involvement is common in rheumatoid arthritis (RA). Foot pain, instability and
deformity affect ambulation and impacts on health-related quality of life. The aim of this
study was to determine the nature, extent and functional impact of rheumatoid foot
problems in established RA.
Patients and Methods
One hundred RA patients were studied. Functional status was evaluated using the modified
Health Assessment Questionnaire (mHAQ) and Foot Health Status Questionnaire (FHSQ).
Foot deformity and footwear suitability was assessed using the Foot Problems Survey (FP
Survey) and Footwear Suitability Scale (FWS Scale).
Results
In this predominantly female group of 95%, with a mean (± SD) disease duration of 12.2
(7.9) and moderate functional disability [mHAQ: 1.3 (0.6)], the FP Survey showed all
patients had one or more foot deformity. Foot function was impaired with a mean (± SD)
FHSQ score of 41.3 (12.4) and the FWS Scale showed that 93% wore unsuitable footwear.
A strong correlation was observed of the global FHSQ (r=-0.5489, p<0.0001), its pain
domain (r=-0.472, p<0.0001) and foot function domain (r=-0.599, p<0.0001), with the
global mHAQ score. Despite the high frequency of foot problems observed only 27% had
visited a podiatrist.
Conclusion
In conclusion foot problems and foot function disability is common in Black South African
patients with established RA. Furthermore the strong correlation between mHAQ and
FHSQ showed that foot functional disability was a major driver of overall functional
disability in RA.
|
36 |
Characterisation of scFv A7 reactivity and development of a novel bispecific antibody for targeted therapies in Rheumatoid ArthritisFerrari, Mathieu January 2014 (has links)
Despite the success of current biological agents, achievement of broader efficacy and improved safety profile remains an unmet need in rheumatoid arthritis therapy. Neovasculogenesis plays a vital role in the progression and perpetuation of rheumatoid arthritis and significant evidence has demonstrated molecular heterogeneity within the endothelium (MVE) of different tissues. The heterogeneity of the synovial MVE can be exploited for the development of organ-specific therapeutic and diagnostic reagents. A novel recombinant antibody fragment, scFv A7, with specificity for human arthritic synovium, was isolated in our laboratory following in vivo phage display. The aim of the project described in this thesis is to characterise the antibody reactivity and develop a novel tissue specific therapeutic. The scFv A7 antibody proved to specifically target the microvasculature of human arthritic synovium with no detectable reactivity in a comprehensive range of normal tissues. Furthermore, the detected reactivity was not a common feature of chronic inflammatory conditions. Hence, the A7 antibody represents a unique and versatile tool with great potential for the development of diagnostic and/or therapeutic agents. The unique properties of A7 were combined with the anti-TNF Adalimumab, forming a bispecific antibody with neutralising activity and synovial homing properties. The new construct was able to retain the synovial specificity and showed comparable TNF binding kinetics and biological activity to the parent Adalimumab antibody in vitro. In conclusion, these results demonstrate that scFv A7 reactivity is specific to the microvasculature of human arthritic synovium, suggesting that the target molecule may have potential as a biomarker in arthritis and applications as an immunotherapeutic target. The bispecific antibody format developed showed unaltered TNF blocking capacity and synovial specificity that may allow reduction in the dosage and/or administration frequency, with the ultimate goal to reduce the systemic exposure, achieve a better therapeutic index and decreasing health care costs.
|
37 |
A preliminary investigation of periodontal disease and rheumatoid arthritis /Dong, Xiaoxiao. January 2005 (has links)
Thesis (M. D. S.)--University of Hong Kong, 2005.
|
38 |
Explanatory models of rheumatoid arthritisSamford Fair, Betty Susan, 1953- 17 May 2011 (has links)
Not available / text
|
39 |
The diagnostic and prognostic value of anti-CCP assay in the juvenile idiopathic arthritis (JIA)Hui, Kwun-ho., 許冠浩. January 2004 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
40 |
The role of self-efficacy in rheumatoid arthritis patientsChu Sok-iam, Peony January 1994 (has links)
published_or_final_version / abstract / toc / Clinical Psychology / Master / Master of Social Sciences
|
Page generated in 0.0699 seconds